Hapag-Lloyd and United Arab Shipping Company Monday signed a merger agreement that will create the world’s fifth-largest container shipping line and strengthen the competitiveness of THE Alliance.
The sovereign wealth funds of Qatar and Saudi Arabia, which control UASC, will own 14 percent and 10 percent respectively of the merged carrier.
The merger, which is subject to regulatory and contractual approvals, is expected to be finalized by the end of the year, Hapag-Lloyd said.
The agreement commits some of Hapag-Lloyd’s existing and future shareholders to raise $400 million via a share sale within six months of the closing of the transaction.
The merged carrier will have a fleet of 237 vessels with a total capacity of around 1.6 million 20-foot-equivalent units, an annual transport volume of 10 million TEUs and a combined revenue of approximately $12 billion.
“This strategic merger makes a lot of sense for both carriers as we are able to combine UASC’s emerging global presence and young and highly efficient fleet with Hapag-Lloyd’s broad, diversified market coverage and a strong customer base,” said Rolf Habben Jansen, CEO of Hamburg-based Hapag-Lloyd. “Furthermore, it will give the new Hapag-Lloyd access to ultra-large container vessels.”
“After the successful integration of CSAV, which was concluded mid of 2015, this transaction with UASC is another historic milestone for Hapag-Lloyd.”
Full Content: JOC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas